Condition
Malignant Mesothelioma
Estimated Enrollment: 45
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: ELCWP-01062
Study First Received: March 5, 2008
Last Updated: February 11, 2015
Estimated Primary Completion Date: March 2009
Primary Outcome Measures:
Response rate|Survival|Toxicity
Sponsors and Collaborators:
European Lung Cancer Working Party
Website Link: https://ClinicalTrials.gov/show/NCT00634205
